Cdk8 Antibody [G17E8]

Catalog No.: F9887

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:30
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    53 kDa 53 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Cdk8 Antibody [G17E8] detects endogenous levels of total Cdk8 protein.
    Clone
    G17E8
    Synonym(s)
    Cyclin-dependent kinase 8, Cell division protein kinase 8, Mediator complex subunit CDK8, Mediator of RNA polymerase II transcription subunit CDK8, Protein kinase K35, CDK8
    Background
    CDK8 is a cyclin‑dependent kinase that functions as the catalytic core of the CDK8 kinase module within specific Mediator complexes and acts as a transcription‑regulatory kinase that integrates signaling inputs into RNA polymerase II–dependent gene expression programs. The kinase associates with cyclin C, MED12, and MED13 to form the CDK8 subcomplex, which binds the Mediator core in a reversible manner, and this configuration positions the CDK8 active site to phosphorylate components of the basal transcription machinery, transcription factors, and elongation regulators without being required for Mediator assembly itself. CDK8 phosphorylates transcription factors and coactivators, including members of the serum response and early growth response networks, and also targets the carboxy‑terminal domain of RNA polymerase II and elongation‑associated factors, which modulate the transition from initiation to productive elongation and the assembly and activity of the positive transcription elongation factor b–containing elongation complex. Within the serum response network, CDK8 acts as a positive regulator of transcriptional elongation by facilitating recruitment of P‑TEFb and BRD4 to promoters and enhancers and by preventing accumulation of hypophosphorylated, slow‑elongating RNA polymerase II complexes, which results in efficient induction of immediate‑early genes such as AP‑1 and EGR family transcription factors after mitogenic stimulation. The CDK8 kinase module also exerts context‑dependent repressive functions; Mediator complexes containing the CDK8 subcomplex can block preinitiation complex formation at some promoters and modulate the interaction between Mediator and RNA polymerase II, thereby controlling access of the basal machinery to specific transcription factor–bound regulatory regions. CDK8 activity participates in multiple signaling pathways, including Wnt/β‑catenin, TGF‑β/Smad, STAT, and nuclear hormone receptor pathways, by phosphorylating pathway‑specific transcription factors and co‑regulators and by adjusting the amplitude and duration of their transcriptional outputs, which link extracellular cues and oncogenic signaling to Mediator‑dependent gene expression. The CDK8 kinase module regulates sets of genes involved in metabolism, cell‑cycle progression, and survival, and acts as a node in life‑and‑death decisions through transcriptional control of apoptotic and autophagy genes and non‑transcriptional roles of cyclin C in mitochondrial dynamics.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください